Cytokinetics, Inc. (CYTK)

66.71 +1.29 (+1.97%) USD  |  NASDAQ  |  Apr 17, 16:00
66.69 -0.02 (-0.03%) Pre-Market: 20:00
More

Cytokinetics Total Operating Expenses (% of Quarterly Revenues)

Total Operating Expenses (% of Quarterly Revenues) Chart

View Total Operating Expenses (% of Quarterly Revenues) for CYTK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Operating Expenses (% of Quarterly Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years

View Total Operating Expenses (% of Quarterly Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Operating Expenses (% of Quarterly Revenues) Benchmarks

View Total Operating Expenses (% of Quarterly Revenues) Benchmarks
Start Trial
Bristol Myers Squibb Co. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
AtriCure, Inc. Upgrade
Johnson & Johnson Upgrade
Corcept Therapeutics, Inc. Upgrade